ArticleThe Lancet. Infectious diseases2017
Drug-resistant tuberculosis threatens WHO's End-TB strategy.
Article in The Lancet. Infectious diseases, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed.
- Risk Factors of Latent Tuberculosis Infection among Incarcerated Populations: A Case-Control Study in Shenzhen, China.Journal of epidemiology and global health · 2026Article
- Global burden of multidrug-resistant tuberculosis in children and adolescents.Pediatric research · 2025Article
- Multidrug-Resistant Tuberculosis Treatment Outcome and Associated Factors at the University of Gondar Comprehensive Specialized Hospital: A Ten-Year Retrospective Study.Infection and drug resistance · 2022Article
- Trends in burden of multidrug-resistant tuberculosis in countries, regions, and worldwide from 1990 to 2017: results from the Global Burden of Disease study.Infectious diseases of poverty · 2021Article
- Effects of secondary infections on the multidrug-resistant Tuberculosis: A cohort study.Medical journal of the Islamic Republic of Iran · 2021Article
- Age-stratified anti-tuberculosis drug resistance profiles in South Korea: a multicenter retrospective study.BMC infectious diseases · 2020Article
- A Review of Clinical Pharmacokinetic and Pharmacodynamic Relationships and Clinical Implications for Drugs Used to Treat Multi-drug Resistant Tuberculosis.European journal of drug metabolism and pharmacokinetics · 2020Review
- Prevalence of drug-resistant tuberculosis in Zimbabwe: A health facility-based cross-sectional survey.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2019Article
- Change in prevalence and molecular characteristics of isoniazid-resistant tuberculosis over a 10-year period in China.BMC infectious diseases · 2019Article
- Drug susceptibility testing and mortality in patients treated for tuberculosis in high-burden countries: a multicentre cohort study.The Lancet. Infectious diseases · 2019Article
- Article
- Paediatric Palliative Care in Resource-Poor Countries.Children (Basel, Switzerland) · 2018Review
- Drug resistant tuberculosis in Africa: Current status, gaps and opportunities.African journal of laboratory medicine · 2018Article
Corrections and comments
- Commented on by
- Comment on
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
28499827What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.